QUICK RESULTS

Lay out a treatment plan as early as the first patient meeting.

Agendia provides you with actionable insights throughout your patient’s breast cancer journey.

QUICK RESULTS

Lay out a treatment plan as early as the first patient meeting.

Agendia provides you with actionable insights throughout your patient’s breast cancer journey.

Learn the likelihood of a patient’s breast cancer recurring.

A RISK OF RECURRENCE TEST

Determine the underlying genomics driving the growth of a tumor.

A MOLECULAR SUBTYPING TEST

FOR BETTER OUTCOMES

A more complete understanding of each patient’s breast cancer.

Agendia’s genomic testing platforms help you match each patient to the right treatment at the right time to help minimize under- and over-treatment, and improve their quality of life.

Order A Test

FOR PROVEN RESULTS

Trusted by leading physicians and institutions around the world

Landmark Studies

Data on the validation and utility of MammaPrint and BluePrint for patients with early stage breast cancer.

Review our data

Are you a breast cancer patient?

Learn more about how genomic testing can improve your path to recovery.

VISIT OUR PATIENT ADVOCACY SITE

Are you a breast cancer patient?

Learn more about how genomic testing can improve your path to recovery.

VISIT OUR PATIENT ADVOCACY SITE